Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC28488767;8768;8769 chr2:178770159;178770158;178770157chr2:179634886;179634885;179634884
N2AB28488767;8768;8769 chr2:178770159;178770158;178770157chr2:179634886;179634885;179634884
N2A28488767;8768;8769 chr2:178770159;178770158;178770157chr2:179634886;179634885;179634884
N2B28028629;8630;8631 chr2:178770159;178770158;178770157chr2:179634886;179634885;179634884
Novex-128028629;8630;8631 chr2:178770159;178770158;178770157chr2:179634886;179634885;179634884
Novex-228028629;8630;8631 chr2:178770159;178770158;178770157chr2:179634886;179634885;179634884
Novex-328488767;8768;8769 chr2:178770159;178770158;178770157chr2:179634886;179634885;179634884

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Ig-18
  • Domain position: 54
  • Structural Position: 135
  • Q(SASA): 0.1874
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/L None None 0.835 N 0.498 0.231 0.454987352986 gnomAD-4.0.0 1.59046E-06 None None None None N None 0 0 None 0 0 None 0 0 0 0 3.02133E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.5206 ambiguous 0.5077 ambiguous -1.858 Destabilizing 0.122 N 0.216 neutral N 0.4866082 None None N
V/C 0.9022 likely_pathogenic 0.9171 pathogenic -1.255 Destabilizing 1.0 D 0.698 prob.neutral None None None None N
V/D 0.8799 likely_pathogenic 0.8589 pathogenic -2.247 Highly Destabilizing 0.994 D 0.784 deleterious N 0.503775787 None None N
V/E 0.7397 likely_pathogenic 0.7279 pathogenic -2.207 Highly Destabilizing 0.996 D 0.725 prob.delet. None None None None N
V/F 0.4224 ambiguous 0.4299 ambiguous -1.343 Destabilizing 0.994 D 0.753 deleterious N 0.512652949 None None N
V/G 0.5676 likely_pathogenic 0.5513 ambiguous -2.215 Highly Destabilizing 0.925 D 0.721 prob.delet. N 0.507473517 None None N
V/H 0.8714 likely_pathogenic 0.8718 pathogenic -1.777 Destabilizing 1.0 D 0.75 deleterious None None None None N
V/I 0.0987 likely_benign 0.1126 benign -0.94 Destabilizing 0.248 N 0.24 neutral N 0.506099526 None None N
V/K 0.7928 likely_pathogenic 0.7852 pathogenic -1.587 Destabilizing 0.991 D 0.724 prob.delet. None None None None N
V/L 0.4364 ambiguous 0.5085 ambiguous -0.94 Destabilizing 0.835 D 0.498 neutral N 0.494356381 None None N
V/M 0.2694 likely_benign 0.3182 benign -0.718 Destabilizing 0.996 D 0.658 neutral None None None None N
V/N 0.6247 likely_pathogenic 0.6238 pathogenic -1.479 Destabilizing 0.999 D 0.798 deleterious None None None None N
V/P 0.9945 likely_pathogenic 0.9901 pathogenic -1.215 Destabilizing 0.996 D 0.755 deleterious None None None None N
V/Q 0.6528 likely_pathogenic 0.6503 pathogenic -1.63 Destabilizing 0.999 D 0.753 deleterious None None None None N
V/R 0.7673 likely_pathogenic 0.7357 pathogenic -1.045 Destabilizing 0.996 D 0.796 deleterious None None None None N
V/S 0.5606 ambiguous 0.5598 ambiguous -1.969 Destabilizing 0.942 D 0.697 prob.neutral None None None None N
V/T 0.4116 ambiguous 0.4454 ambiguous -1.83 Destabilizing 0.97 D 0.587 neutral None None None None N
V/W 0.9594 likely_pathogenic 0.9575 pathogenic -1.635 Destabilizing 1.0 D 0.762 deleterious None None None None N
V/Y 0.8077 likely_pathogenic 0.8073 pathogenic -1.361 Destabilizing 0.999 D 0.749 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.